Pfm Health Sciences, LP Myovant Sciences Ltd. Transaction History

Pfm Health Sciences, LP

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 15, 2021	SELL	$18.94 - $26.99 $36.2 Million - $51.6 Million	-1,912,188 Closed	0 $0
Q2 2021 Aug 16, 2021	SELL	$17.07 - $24.56 $2.44 Million - $3.51 Million	-142,740 Reduced 6.95%	1,912,188 $43.5 Million
Q1 2021 May 17, 2021	BUY	$20.46 - $25.18 $20.6 Million - $25.4 Million	1,008,716 Added 96.42%	2,054,928 $42.3 Million
Q4 2020 Feb 16, 2021	BUY	$13.8 - $27.62 $5.77 Million - $11.5 Million	417,940 Added 66.52%	1,046,212 $28.9 Million
Q3 2020 Nov 16, 2020	BUY	$14.05 - $22.6 $8.83 Million - $14.2 Million	628,272 New	628,272 $8.83 Million

61.3K

Ticker MYOV
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 96,802,800
Description
Myovant Sciences Ltd., a biopharmaceutical company, develops redefine care for women and for men. The company's lead product is relugolix, an oral, once-daily, small molecule that acts as a gonadotropin-releasing hormone receptor antagonist for the treatment of heavy menstrual bleeding related with uterine fibroids, endometriosis-associated pain...

Get notified when there are updates to the investment portfolio of Pfm Health Sciences, LP, based on Form 13F filings with the SEC.

Stay updated on Pfm Health Sciences, LP with notifications on news.